REGN SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Regeneron Therapeutics, Inc. Shareholders Have Opportunity to Lead Class Action Lawsuit!
Portfolio Pulse from
A class action lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) by Bronstein, Gewirtz & Grossman, LLC. The lawsuit alleges violations of federal securities laws for those who acquired Regeneron securities between November 2, 2023, and October 30, 2024.
February 28, 2025 | 12:15 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Regeneron Pharmaceuticals is facing a class action lawsuit for alleged violations of federal securities laws. This could lead to potential financial liabilities and impact investor sentiment.
The announcement of a class action lawsuit against Regeneron Pharmaceuticals is likely to negatively impact its stock price in the short term due to potential financial liabilities and negative investor sentiment. Legal issues often lead to uncertainty and can result in stock price volatility.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100